跳至主要内容
临床试验/ACTRN12616001301459
ACTRN12616001301459已完成未知

A Multi-centre, Open Label, Randomised Controlled Trial to Compare a Conservative Fluid Management Strategy to Usual Care in Participants after Cardiac Surgery

Rachael Parke0 个研究点目标入组 700 人开始时间: 2016年9月16日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
700

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
16 Years 至 o limit(—)
性别
All

入选标准

  • 1.Adult participants 16 years or older
  • 2.Having elective cardiac surgery with cardiopulmonary bypass
  • 3.Preoperative EUROSCORE II of 0.9 or greater

排除标准

  • 1. Emergency procedure
  • 2.Contraindication to FloTrac monitoring such as Atrial fibrillation; IABP in situ or anticipated; Open chest;
  • 3.Critical post-operative condition or Participant not expected to survive for more than 24 hours or Open chest
  • 4.ECMO or Ventricular assist device in situ or anticipated
  • 5.Indication for specific fluid management post-operatively such as Adult congenital heart surgery or End stage renal failure requiring dialysis
  • 6.Enrolment not considered to be in the participant's best interest

研究者

发起方
Rachael Parke

相似试验

进行中(未招募)
不适用
?A Multicentre, Randomised, Open-label, Controlled, Two-parallel-group, Phase III Study to Evaluate the Efficacy and Safety of Fondaparinux versus Low-molecular-Weight Heparin (Nadroparin), in Patients Requiring Rigid or Semi-rigid Immobilisation for at least 21 Days and up to 45 Days because of Isolated Non-surgical Below-Knee Injury? - FONDAparinux in patients with a plaster CASTon-surgical below-knee injury, immobilization with a plaster cast or brace, venous thromboembolism, bleeding events.MedDRA version: 9.1Level: LLTClassification code 10049909Term: Venous thromboembolism prophylaxis
EUCTR2008-004181-10-ITGlaxoSmithKline R&D1,350
已完成
4 期
A clinical trial to see the effects and safety of two drugs IVF-M� (Menotropin)and Menopur® (Menotropin) in Infertile Women undergoing IVF treatment
CTRI/2012/05/002656G Life Sciences India Pvt Ltd60
已完成
4 期
A clinical trial to see the effects, safety and patient compliance of two drugs Newmon-R� pre filled syringe and Gonal-F® pen in infertile women undergoing IVF treatment
CTRI/2013/06/003749G Life Sciences India Pvt Ltd120
进行中(未招募)
不适用
A multi-center, randomized, open-label, controlled, one-year trial to measure the effect of zoledronic acid and alendronate on bone metabolism in post menopausal women with osteopenia and osteoporosis - ROSEosteopenia/osteoporosis in postmenopausal womenMedDRA version: 8.1Level: LLTClassification code 10031285Term: Osteoporosis postmenopausal
EUCTR2006-001703-11-DEovartis Pharma GmbH
进行中(未招募)
1 期
This study is to examine whether the combination of a low dose of a new drug Sirolimus in combination with a low dose of the standard anti-rejection medication Tacrolimus is safer and works equally well in patients after liver transplantation.iver transplantationMedDRA version: 19.0Level: LLTClassification code 10050434Term: Prophylaxis against liver transplant rejectionSystem Organ Class: 100000004865
EUCTR2009-017843-32-NLFoundation of Liver Research (SLO)